Dr. Norman Yeh, MD

Dr. Yeh practices at Good Samaritan Regional Medical Center in Corvallis, Oregon, part of MultiCare Health System.

Dr. Yeh's NPI, 1679869283, was assigned on June 22, 2011. Dr. Yeh graduated from Indiana University School of Medicine in 2011. Dr. Yeh holds Oregon license MD185967.

Dr. Yeh's primary practice is Good Samaritan Regional Medical Center, at 3600 NW Samaritan Drive, Corvallis, OR 97339 in Benton County. The practice phone is (541) 768-5111.

Dr. Yeh's primary practice is Good Samaritan Regional Medical Center in Corvallis, Oregon, part of MultiCare Health System. Dr. Yeh is also affiliated with Samaritan Albany General Hospital. The medical group on file is Good Samaritan Regional Medical Center. Dmand AI also links Dr. Yeh to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yeh practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Yeh's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Yeh's licenses on file in 2 states: Oregon and Oklahoma.

CMS data shows 1,352 Medicare services from Dr. Yeh across 14 procedure codes in 2024, for 134 Medicare patients. Medicare paid $109,253 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 134 Medicare patients who saw Dr. Yeh in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have cancer, and 70% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yeh's median patient age at 71, with 56% women.

In 2024, Dr. Yeh wrote 159 Medicare Part D claims for 69 patients. 96% of them were for generic drugs. CMS names the drug for 70 of them, across 4 drugs with 11 or more claims each, at $913 in total drug cost. In 2023, CMS named 147 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Yeh for performance year 2024, reported as part of a group. Dr. Yeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Yeh, published from 2013 to 2017. 2016 was the busiest year, with 3. The most frequent topics are Brain Neoplasms, Insurance Coverage and Carcinoma, Non-Small-Cell Lung. Dr. Yeh has published most often in Int J Radiat Oncol Biol Phys. Dr. Yeh's most frequent co-authors are Laurie Gaspar, MD, Chad George Rusthoven, MD and Sana Dole Karam, MD.

Dmand AI links Dr. Yeh to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Breast Diseases.

CMS Open Payments shows 12 general payments to Dr. Yeh from 8 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $159.

Dr. Yeh graduated from Indiana University School of Medicine in 2011.